RPA1 and neoplasm: With the bioinformatic analyses and biological evidence in current study, we identified a novel germline polymorphism of RPA1 gene (rs1131636) conferring tumor progression and therapeutic resistance in NPC, which ultimately affects the survival of patients with NPC.